Professor Peter Psaltis
Professor
Adelaide Medical School
Faculty of Health and Medical Sciences
Prof Peter J Psaltis (MBBS (Hons), PhD, FRACP, FCSANZ, FESC)
Professor Peter Psaltis is an academic Interventional and Preventative Cardiologist who holds a Level 3 National Heart Foundation Future Leader Fellowship and Faculty positions at the Central Adelaide Local Health Network, University of Adelaide and South Australian Health and Medical Research Institute (SAHMRI). He is the co-Deputy Director of SAHMRI, co-leads its largest research department (Lifelong Health Theme) and leads its Heart and Vascular Health Program. Concurrently, he is Head of Interventional Cardiology at the Royal Adelaide Hospital. Among national and state leadership positions, Peter is a Board Director of the Australian Cardiovascular Alliance and co-Chair of its Coronary Artery Disease Clinical Theme, past-President of the Australian Atherosclerosis Society, co-Chair of the South Australian Aboriginal Heart and Stroke Leadership Group, and co-Chair of the Heart Foundation’s South Australian Cardiovascular Research Network.
Peter has expertise across all three disciplines of basic, translational, and clinical research and leads bench-to-bedside projects spanning topics of developmental macrophage biology, vascular stem cells, inflammatory regulation of atherosclerosis, pharmacological modification of atherosclerosis, coronary plaque imaging, the modelling of biomechanical forces in coronary arteries and cardiometabolic disease. He has received >$22 million of peer-reviewed grant funding and received the 2021 NHMRC Marshall and Warren Award for Innovation. As of early 2025, Peter has published >240 manuscripts and book chapters. His research has global impact and reach, and he ranks in the top 0.05% worldwide for productivity and impact in coronary artery research over the last 5 years, also receiving numerous national and international awards for his scientific discoveries. Peter has supervised 10 EMCRs and graduated 13 PhD (4 as principal supervisor, all Dean’s commendation, including one Doctoral Research Medal) and 12 Hons students (all first class).
- My Research
- Career
- Publications
- Grants and Funding
- Teaching
- Supervision
- Professional Activities
- Contact
Research Overview
Coronary artery disease (CAD) is the leading cause of death worldwide, costing $150 billion/year. Over the last decade, Prof Psaltis’ bench-to-bedside program has made world-first discoveries of new cellular1,2, molecular3,4 and biomechanical5 mechanisms underlying atherosclerosis, and provided key insights on patterns of coronary disease6-8 and post-MI outcomes9-12. Peter’s work has also helped define the responsiveness of coronary plaque to different antiatherosclerotic therapies13-15.
Three themes of his work’s transformative impact include groundbreaking findings of:
- SCAD (spontaneous coronary artery dissection) as a non-atherosclerotic cause of MI 6,16,17;
-
Anti-atherosclerotic properties of the anti-inflammatory drug, COLCHICINE 15,18-20; and
- Ability of PCSK9 inhibitors to stabilise and regress coronary plaque after MI14,21-24.
Peter is also interested in atherosclerotic plaque buildup in arteries following heart attacks. Despite current care standards, heart attack survivors are at high risk of repeat, life-threatening events from continued arterial plaque build-up. His research aims to transform management after a heart attack by using CT imaging to visualise remaining plaque, monitor how it changes over time, and study how it relates to inflammation. This will allow us to better predict an individual’s risk, reduce repeat events, and develop novel treatments 4,8,25.
*Psaltis first/last author. +Psaltis author.
1. *Toledo-Flores D, et al. Vasculogenic properties of adventitial Sca-1(+)CD45(+) progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Sci Rep. 2019;9:7286.
2. *Williamson AE, et al. Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nat Commun. 2024;15:7097.
3. *Fernando S, et al. Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36. FASEB J. 2022;36:e22154.
4. *White JB, et al. Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction. Atherosclerosis. 2025;408:120421.
5. *Carpenter HJ, et al. On the nonlinear relationship between wall shear stress topology and multidirectionality in coronary atherosclerosis. Comput Methods Programs Biomed. 2023;231:107418.
6. *Rashid HN, et al. Incidence and characterisation of spontaneous coronary artery dissection as a cause of acute coronary syndrome--A single-centre Australian experience. Int J Cardiol. 2016;202:336-338.
7. *Bogana Shanmugam V, et al. Outcomes After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Caused by Ectatic Infarct Related Arteries. Heart Lung Circ. 2017;26:1059-1068.
8. *Baumann AAW, et al. Prevalence and real-world management of NSTEMI with multivessel disease. Cardiovasc Diagn Ther. 2022;12:1-11.
9. +Spoon DB, et al. Trends in cause of death after percutaneous coronary intervention. Circulation. 2014;129:1286-1294.
10. +Spoon DB, et al. Prediction of Cardiac and Noncardiac Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2015;8:e002121.
11. *Nguyen MT, et al. Thirty-Day Unplanned Readmissions Following Elective and Acute Percutaneous Coronary Intervention. Heart Lung Circ. 2023;32:619-628.
12. +Nguyen MT, et al. High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use. JAMA Netw Open. 2024;7:e2438541.
13. +Nicholls SJ, et al. Effect of Serial Infusions of CER-001, a Pre-beta High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018;3:815-822.
14. *Nicholls SJ, et al. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in StatinTreated Patients Following Myocardial Infarction. JACC Cardiovasc Imaging. 2022;15:1308-1321.
15. *Psaltis PJ, et al. Optical coherence tomography assessment of the impact of colchicine on nonculprit coronary plaque composition after myocardial infarction. Cardiovasc Res. 2025;121:468-478
16. *Franke KB, et al. Systematic review and meta-analysis of the clinical characteristics and outcomes of spontaneous coronary artery dissection. Int J Cardiol. 2021 Jan 1;322:34-39.
17. +Dang QM, et al. The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence. Eur Heart J. 2025 Jun 2;46(21):2012-2023.
18. *Schwarz N, et al. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. FASEB J. 2023 Apr;37(4):e22846.
19. *Montarello NJ, et al. Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study. Cardiovasc Drugs Ther. 2022 Dec;36(6):1175-1186.
20. *Psaltis PJ, et al. Persistent inflammation after myocardial infarction: Elevated IL-6 associates with impaired coronary plaque stabilisation despite optimal therapy. Eur J Prev Cardiol. 2025 Sep 1:zwaf563.
21. *Nicholls SJ, et al. Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. Cardiovasc Diagn Ther. 2021 Feb;11(1):120-129.
22. *Nicholls SJ, et al. Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. JACC Cardiovasc Imaging. 2023 Jan;16(1):130-132.
23. +Fujino M, et al. Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS. Atherosclerosis. 2025 Apr;403:119145.
24. +Di Giovanni G, et al. Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. Eur J Prev Cardiol. 2025 Apr 8:zwaf211.
25. *Allahwala M, et al. Type 2 Diabetes and Acute Myocardial Infarction: Insights into Admission Complexity and Readmission Rates in a Tertiary Centre. Heart Lung Circ. 2025 Sep 11.
Projects available for Honours 2026 and 2027
Project 1
Title: Human EndoMac progenitor cells - Isolation and characterisation
Description: Blood vessel formation is essential for tissue development, growth, and repair. Macrophages and endothelial cells play interlinked roles in blood vessel formation. In adult tissues, these cell types are thought to originate independently of each other. We have discovered unique adult stem cells in mouse tissues termed Endothelial-Macrophage (EndoMac) progenitor cells that give rise to both macrophages and endothelial cells and contribute to blood vessel formation after tissue injury. We have found analogous cells in human tissues. This project aims to isolate, characterise, and investigate the properties of human EndoMac progenitor cells, for therapeutic manipulation.
Project 2
Title: Investigating mechanisms underlying pathogenesis of scleroderma-related vasculopathy
Description: Scleroderma, a chronic autoimmune disorder, is characterised by inflammation, vasculopathy and fibrosis of the skin and internal organs. Vasculopathy can affect both micro- and macro- blood circulation, resulting in blue fingertips or Raynaud’s phenomenon, fingertip ulcers, and lung and renal complications. Injury and dysfunction of endothelial cells, the building blocks of blood vessels, are thought to trigger vasculopathy of the skin that manifests as Raynaud’s phenomenon but the causes are poorly understood. This project will investigate the role of cellular senescence and autophagy in endothelial cell injury/ dysfunction and fingertip ulcers in scleroderma, to identify biomarkers for early diagnosis and disease management.
Supervisors: Peter Psaltis, Shiwani Sharma, Sanuri Liyanage
Projects available for: Honours and Masters
Location: South Australian Health and Medical Research Institute, Level 6 South
Research projects start: Semester 1 and 2
-
Appointments
Date Position Institution name 2025 - ongoing Co-Deputy Director South Australian Health and Medical Research Institute 2024 - ongoing Level E Professor University of Adelaide 2023 - 2025 Deputy Director South Australian Health and Medical Research Institute 2021 - ongoing Head, Interventional Cardiology, Department of Cardiology Royal Adelaide Hospital 2021 - ongoing Co-Lead, Lifelong Health Theme South Australian Health and Medical Research Institute 2021 - ongoing Program Lead, Heart and Vascular Health South Australian Health and Medical Research Institute 2016 - 2021 Deputy Leader, Heart and Vascular Health Program, Lifelong Health Theme South Australian Health and Medical Research Institute 2015 - ongoing Senior Research Fellow, Level C The University of Adelaide 2015 - ongoing Co-Director, Vascular Research Centre South Australian Health and Medical Research Institute 2015 - ongoing Consultant Cardiologist Adelaide Heart Clinic 2015 - ongoing Clinical Academic and Consultant Interventional Cardiologist Central Adelaide Local Health Network 2013 - 2014 Post-doctoral Research Fellow Monash University 2013 - 2014 Interventional Cardiology Fellow Monash Health 2010 - 2014 Post-doctoral Research Fellow University of Adelaide 2010 - 2012 Senior Research Fellow Mayo Clinic, Rochester 2009 - 2012 Post-doctoral Research/Senior Research Fellow Mayo Clinic 2004 - 2014 Senior Lecturer University of Adelaide -
Awards and Achievements
Date Type Title Institution Name Country Amount 2021 Award NHMRC Marshall and Warren Innovation Award, Most Innovative Ideas Grant for 2020 Round National Health and Medical Research Council Australia - 2021 Award Best Cover Paper Journal of Clinical Medicine Australia - 2016 Research Award Best Research Award, 5th International Congress on Lipid Metabolism and Atherosclerosis 5th International Congress on Lipid Metabolism and Atherosclerosis Korea, Republic of - 2013 Recognition Top Ten Abstract Gordon Research Conference - Atherosclerosis, Stowe United States - 2011 Award Early Career Investigator Award (Inaugural), American Heart Association Scientific Sessions Meeting, Orlando, FL, USA Arteriosclerosis Thrombosis and Vascular Biology Council United States - 2011 Award Best Poster Presentation Award, Mayo Research Fellows’ Association Mayo Clinic United States - 2011 Recognition Top Ten Abstract Gordon Research Conference - Atherosclerosis United States - 2009 Award The Ross Wishart Memorial Award for the Best Young Investigator Australian Society of Medical Research Australia - 2009 Award Best mini-oral Presentation - Runner-up Award, Australasian Section, 33rd Annual Scientific Meeting International Society for Heart Research Australia - 2009 Recognition Top 5% Abstract Ranking Cardiac Society of Australia and New Zealand Australia - 2009 Award Nimmo Prize, Best Oral Research Presentation Royal Adelaide Hospital Australia - 2008 Award Best Poster Prize, Research Expo The University of Adelaide Australia - 2007 Award Hugh Gilmore Prize, Best Oral Research Presentation Royal Adelaide Hospital Australia - 2006 Scholarship First ranked application, National Heart Foundation Post-Graduate Scholarship National Heart Foundation Australia - 2004 Teaching Award Outstanding Teaching and Service to Medical Students The University of Adelalaide Australia - 2004 Award Best Registrar Award, Selected by Interns Royal Adelaide Hospital Australia - 2003 Teaching Award Outstanding Teaching and Service to Medical Students The University of Adelaide Australia - -
Education
Date Institution name Country Title 2023 European Society of Cardiology France Fellowship 2015 Cardiac Society of Australia and New Zealand Australia Fellowship 2010 University of Adelaide Australia Doctor of Philosophy 2006 Royal Australasian College of Physicians Australia Fellowship (Cardiology and Internal Medicine) 1999 University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery -
Research Interests
-
Journals
-
Book Chapters
Year Citation 2022 Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2022). Effect of Nonlinear Blood Viscosity on LDL Transport and Fluid-Structure Interaction Biomechanics of a Multi-stenosis Left Circumflex Coronary Artery. In W. Lacarbonara (Ed.), NODYCON Conference Proceedings Series (pp. 39-48). Springer International Publishing.
DOI2021 Gholipour, A., Carpenter, H. J., Hajghayesh, M. H., Zander, A., & Psaltis, P. J. (2021). Effect of Blood Flow Models on the Flow-Induced Vibrations of Coronary Arteries. In S. Oberst, B. Halkon, & J. Ji (Eds.), Vibration Engineering for a Sustainable Future (Vol. 3, pp. 345-351). Switzerland: Springer International Publishing.
DOI2020 Fernando, S., Bursill, C. A., Nicholls, S. J., & Psaltis, P. J. (2020). Pathophysiology of Atherosclerosis. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists Third Edition (pp. 19-45). Springer International Publishing.
DOI Scopus62020 Nankivell, V., Primer, K., Vidanapathirana, A., Psaltis, P., & Bursill, C. (2020). Vascular Biology of Smooth Muscle Cells and Restenosis. In R. Fitridge (Ed.), Mechanisms of Vascular Disease A Textbook for Vascular Specialists (3rd ed., pp. 117-139). Cham, Switzerland: Springer.
Scopus5 -
Conference Papers
Year Citation 2025 O'Brien, J., Easey, K., Redwood, E., Ford, T., Marathe, J., Psaltis, P., . . . Wong, D. (2025). A Prospective Observational Study of Diagnostic Accuracy and Feasibility of Quantitative Flow Ratio When Compared to Fractional Flow Reserve. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 85 (pp. 2 pages). SOUTH KOREA, Seoul: ELSEVIER SCIENCE INC. 2024 Bursill, C., Sandeman, L., Layland, M., Lee, D., Nankivell, V., Tan, J., . . . Abell, A. (2024). DIROXIMEL FUMARATE REDUCES ATHEROSCLEROTIC PLAQUE SIZE AND INSTABILITY. In ATHEROSCLEROSIS Vol. 399 (pp. 2 pages). OMAN, Muscat: ELSEVIER IRELAND LTD.
DOI2024 Bursill, C., Pullen, B. J., Debebe, D., Sandeman, L., Wattchow, N. E., Vidanapathirana, A., . . . Packer, N. H. (2024). Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo. In Abstracts of the European Society of Cardiology Congress (ESC, 2024) as published in European Heart Journal Vol. 45 (pp. ehae6663875-1). London, England and Virtual Online: Oxford University Press.
DOI2024 Solly, E. L., Bouman Chen, Z., Luo, Y., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., . . . Tan, J. T. M. (2024). Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1. In EUROPEAN HEART JOURNAL Vol. 45 (pp. 1 page). ENGLAND, London: OXFORD UNIV PRESS.
DOI WoS12024 Dang, Q., Psaltis, P., Burgess, S., Chandrasekhar, J., Mukherjee, S., Kritharides, L., . . . Zaman, S. (2024). Predictors of Major Adverse Cardiovascular Events: First Report From the Australian-New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry. In Heart Lung and Circulation Vol. 33 (pp. S366-S367). Elsevier BV.
DOI2023 Liyanage, S., Williamson, A., Salagaras, T., Hassanshahi, M., Long, A., Tran, D., . . . Psaltis, P. (2023). Inhibitory And Metabolic Effects Of Diabetes On Yolk Sacderived Endothelial-macrophage Progenitors In Postnatal Murine Tissues. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 43 (pp. 2 pages). PA, Philadelphia: LIPPINCOTT WILLIAMS & WILKINS.
DOI2022 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., & Psaltis, P. J. (2022). Dynamical influences of different aneurysm sizes on rupture risk of abdominal aorta. In Proceedings of the 1st International Conference on Mechanical System Dynamics (ICMSD 2022) Vol. 2022 (pp. 33-38). Hybrid Conference, Nanjing, China: Institution of Engineering and Technology.
DOI Scopus12022 Solly, E. L., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2022). Inhibition of microRNA-181c rescues diabetes-impaired angiogenesis through activation of key angiogenesis mediators. In DIABETOLOGIA Vol. 65 (pp. S25-S26). Stockholm, SWEDEN: SPRINGER. 2022 Wang, X., Ghayesh, M. H., Kotousov, A., Zander, A. C., & Psaltis, P. J. (2022). Wall Shear Stress for an Aorta with Aneurysms Via Computational Fluid Dynamics. In Advances in Nonlinear Dynamics. NODYCON Conference Proceedings Series (pp. 27-37). Switzerland: Springer International Publishing.
DOI2021 Carpenter, H. J., Gholipour, A., Hajghayesh, M., Zander, A., & Psaltis, P. J. (2021). Flow-Induced Dynamics of Bifurcated Coronary Arteries. In Vibration Engineering for a Sustainable Future: Numerical and Analytical Methods to Study Dynamical Systems, Vol. 3 (pp. 339-344). Switzerland: Springer International Publishing.
DOI Scopus12021 Heath, S. J., Carpenter, H. J., Ghayesh, M. H., Zander, A. C., & Psaltis, P. J. (2021). Fluid-Elastic Versus Computational Fluid Dynamics Techniques in the Biomechanical Analysis of Coronary Arteries. In 10th Australasian Congress on Applied Mechanics 2021, ACAM 2021 (pp. 686-698). Virtual, Online: Engineers Australia. 2021 Hiwase, D., Leslie, A., Montarello, N., Friel, O., Chhetri, R., & Psaltis, P. (2021). BURDEN AND MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN MYELODYSPLASTIC SYNDROME (MDS). In LEUKEMIA RESEARCH Vol. 108 (pp. S8). PERGAMON-ELSEVIER SCIENCE LTD. 2020 Carpenter, H. J., Gholipour, A., Ghayesh, M. H., Zander, A., & Psaltis, P. J. (2020). IN VIVO BASED BIOMECHANICS OF THE LEFT MAIN CORONARY BIFURCATION REGION. In ATHEROSCLEROSIS Vol. 315 (pp. E23). ELSEVIER IRELAND LTD. 2019 Bursill, C., Primer, K. R., Solly, E., Psaltis, P. J., & Tan, J. T. M. (2019). High-density lipoproteins rescue diabetes-impaired angiogenesis by restoring cellular metabolic reprogramming responses to hypoxia. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 337). FRANCE, Paris: OXFORD UNIV PRESS.
WoS12019 Pisaniello, A. D., King, P., Di Bartolo, B. A., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Nicholls, S. (2019). IMPACT OF FISH OIL SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN HEALTHY VOLUNTEERS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2091). New Orleans, LA: ELSEVIER SCIENCE INC.
DOI2018 Gholipour, A., Ghayesh, M., Zander, A., Nicholls, S., & Psaltis, P. (2018). Fluid-structure analysis of an atherosclerotic coronary artery. In Proceedings of the 21st Australasian Fluid Mechanics Conference (AFMC 2018) (pp. 1-4). Adelaide, Australia: Australian Fluid Mechanics Society. 2018 Akers, E. J., Mulangala, J., Psaltis, P. J., Bursill, C., Nicholls, S. J., & Di Bartolo, B. A. (2018). Lipoproteins and their Modified Forms Regulate Smooth Muscle Cell Calcification. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS.
DOI2018 Mulangala, J., Akers, E. J., Solly, E. L., Psaltis, P. J., Tan, J. T., Nicholls, S. J., . . . Di Bartolo, B. A. (2018). Elevated Calcium Drives Inflammatory-Driven Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS.
DOI2018 Shanmugam, V. B., & Psaltis, P. (2018). BIFURCATIONAL PERCUTANEOUS CORONARY INTERVENTION IN ST ELEVATION MYOCARDIAL INFARCTION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 72 (pp. B165). CA, San Diego: ELSEVIER SCIENCE INC. 2018 Shishikura, D., Kataoka, Y., Di Giovanni, G., Janssan, A., Takata, K., Andrews, J., . . . Nicholls, S. (2018). Progression of Plaque Attenuation and Echogenicity Associates With Major Adverse Cardiovascular Events; Insights From Intravascular Ultrasound.. In CIRCULATION Vol. 138 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. 2017 Shishikura, D. S., Kataoka, Y. K., Honda, S. H., Takata, K. T., Kim, S. K., Andrews, J. A., . . . Nicholls, S. J. N. (2017). The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 232). SPAIN, Barcelona: OXFORD UNIV PRESS. 2017 Takata, K., Honda, S., Sidharta, S., Duong, M., Shishikura, D., Kim, S., . . . Nicholls, S. J. (2017). Association between cholesterol efflux capacity and coronary plaque lipid composition on near infrared spectroscopy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 467). OXFORD UNIV PRESS. 2017 Honda, S., Kataoka, Y., Shishikura, D., Takata, K., Andrew, J., Butters, J., . . . Nicholls, S. J. (2017). Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 117-118). Barcelona, SPAIN: OXFORD UNIV PRESS. 2016 Munnur, R. K., McCormick, L., Ko, B., Psaltis, P., Cameron, J., Meredith, I., . . . Wong, D. (2016). DIAGNOSTIC ACCURACY OF ASLA SCORE (A NOVEL CT ANGIOGRAPHIC INDEX) AND AGGREGATE PLAQUE VOLUME IN THE ASSESSMENT OF FUNCTIONAL SIGNIFICANCE OF CORONARY STENOSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 1673). IL, Chicago: ELSEVIER SCIENCE INC.
DOI2016 Raphael, C. E., Spoon, D., Bell, M., Psaltis, P. J., Kidd, S., Loh, S. X., . . . Gulati, R. (2016). IMPACT OF THROMBOCYTOPENIA ON PROGNOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 185). IL, Chicago: ELSEVIER SCIENCE INC.
DOI2014 Nerlekar, N., Nasis, A., Ko, B., Leung, M., Cameron, J., Wong, D., . . . Seneviratne, S. (2014). IMPACT OF HEART RATE ON DIAGNOSTIC ACCURACY OF SECOND GENERATION 320-DETECTOR COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1051). ELSEVIER SCIENCE INC.
DOI2013 Spoon, D. B., Psaltis, P. J., Kidd, S., Prasad, A., Lennon, R., Singh, M., & Gulati, R. (2013). OUTCOMES AFTER PCI IN PATIENTS WITH THROMBOCYTOPENIA. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 61 (pp. E1718). CA, San Francisco: ELSEVIER SCIENCE INC.
DOI2013 Spoon, D. B., Psaltis, P. J., Holmes, D., Simari, R., Gersh, B., Lennon, R., . . . Gulati, R. (2013). TEMPORAL TRENDS IN THE CAUSE OF LONG-TERM DEATH AFTER PCI: A 20-YEAR SINGLE-CENTER EXPERIENCE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 61 (pp. E1590). CA, San Francisco: ELSEVIER SCIENCE INC.
DOI2013 Spoon, D. B., Psaltis, P. J., Singh, M., Holmes, D. R., Gersh, B. K., Rihal, C. S., . . . Gulati, R. (2013). Trends in Cause of Long-Term Death After Percutaneous Coronary Intervention. In CIRCULATION Vol. 128 (pp. 1 page). TX, Dallas: LIPPINCOTT WILLIAMS & WILKINS. 2012 Spoon, D. B., Psaltis, P. J., Hoffman, S. J., Witt, T. A., Lerman, A., Khosla, S., & Simari, R. D. (2012). Delivery of Osteocalcin (OCN plus ) Expressing Myeloid Cells is Sufficient to Generate Vascular Calcification. In CIRCULATION Vol. 126 (pp. 1 page). LIPPINCOTT WILLIAMS & WILKINS. 2011 Psaltis, P. J., Peterson, K., Xu, R., Franchi, F., Chen, I. Y., Simari, R. D., . . . Rodriguez-Porcel, M. G. (2011). In vivo Imaging of Oxidative Stress in Mesenchymal Stromal Cells Transplanted After Myocardial Ischemia/Reperfusion Injury. In CIRCULATION Vol. 124 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. 2011 Psaltis, P. J., Harbuzariu, A., Delacroix, S., Witt, T., Kleppe, L., Mueske, C., . . . Simari, R. D. (2011). Sca-1 Identifies a Monocyte-Predisposed Hierarchy of Hematopoietic Progenitor Cells in the Postnatal Murine Aorta. In CIRCULATION Vol. 124 (pp. 1 page). LIPPINCOTT WILLIAMS & WILKINS. 2010 Delacroix, S., Boylan, B. J., Harbuzariu, A., Psaltis, P. J., Pan, S., Holroyd, E., . . . Simari, R. D. (2010). NPR-B Expression In Megakaryocytes and Platelets.. In BLOOD Vol. 116 (pp. 1751-1752). FL, Orlando: AMER SOC HEMATOLOGY. 2010 Harbuzariu, A., Psaltis, P. J., Witt, T. A., Kleppe, L. S., Delacroix, S., Holroyd, E. W., . . . Simari, R. D. (2010). Bone Marrow Mononuclear Cells Contribute to the Vascular Hematopoietic Niche. In CIRCULATION Vol. 122 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. 2010 Lau, D. H., Carbone, A., Psaltis, P. J., Mackenzie, L., Metcalf, R., Kuklik, P., . . . Sanders, P. (2010). ATRIAL PROTECTIVE EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS: A LONG TERM STUDY IN OVINE CHRONIC HEART FAILURE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 55 (pp. 1 page). ELSEVIER SCIENCE INC. 2009 Psaltis, P. J., Worthley, S. G., See, F., Itescu, S., Martens, T., Gronthos, S., & Zannettino, A. (2009). Enrichment for Stro-1 Enhances Paracine-mediated Cardiovascular Repair From Human Bone Marrow Mesenchymal Cells. In CIRCULATION Vol. 120 (pp. S821). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2009 Psaltis, P. J., Carbone, A., Manavis, J., Jantzen, T., Lau, D., Sanders, P., . . . Worthley, S. G. (2009). Catheter-based Electromechanical Mapping Accurately Characterizes Segmental Distribution of Left Ventricular Fibrosis in Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S906). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2009 Psaltis, P. J., Zannettino, A., Carbone, A., Manavis, J., Williams, K., Jantzen, T., . . . Worthley, S. G. (2009). Cardiac Repair With Transendocardial Injection of Allogeneic Mesenchymal Precursor Cells for Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S827). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2007 See, F., Seki, T., Psaltis, P., Martens, T., Gronthos, S., Worthley, S., . . . Itescu, S. (2007). Human stroll mesenchymal precursor cells induce proliferative effects on vascular smooth muscle cells and endothelium via P13 kinase dependent pathways. In CIRCULATION Vol. 116 (pp. 104). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2004 Roberts-Thomson, K. C., Psaltis, P. J., Kee, P., & Young, G. D. (2004). Long term follow up of patients undergoing electrophysiological study on amiodarone. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY Vol. 37 (pp. 264). Brisbane, AUSTRALIA: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. -
Conference Items
Year Citation 2024 Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2024). Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press.
DOI WoS12022 Nankivell, V. A., Vidanapathirana, A., Rajora, M., Psaltis, P., Tan, J. T., Tieu, W., . . . Bursill, C. A. (2022). Theranostic Properties of Porphysome Nanoparticles in Atherosclerotic Cardiovascular Disease. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
WoS22022 Primer, K. R., Tan, J. T., Psaltis, P. J., & Bursill, C. A. (2022). Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. 2022 Pullen, B. J., Vidanapathirana, A. K., Sandeman, L., Everest-Dass, A., Kolarich, D., Tan, J. T., . . . Bursill, C. A. (2022). Deletion of the Asialyloglycoprotein Receptor-1 Causes Athero-Protective Effects in vitro and in vivo. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
WoS22022 Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., . . . Verjans, J. W. (2022). Cardiovascular disease risk prediction via machine learning using mental health data. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. 2019 Fernando, S., Schwarz, N., Sandeman, L., Skoumbourdis, T., Zareh, J., Williamson, A., . . . Psaltis, P. J. (2019). Eukaryotic Elongation Factor 2 Kinase Regulates Cholesterol Uptake by Macrophages via Cd36 Scavenger Receptor Expression. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. 2019 Wong, N. K., Solly, E., Nicholls, S., Psaltis, P., Ng, M. K., Bursill, C. A., & Tan, J. T. (2019). <i>TRIM2</i> an<i>d CREBRF</i> Are Novel Regulators of Angiogenic Functions in Human Coronary Artery Endothelial Cells. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. 2019 Williamson, A., Toledo, D. F., Schwarz, N., Fernando, S., Dimasi, C., Liyanage, S., . . . Psaltis, P. J. (2019). Postnatal mouse aorta contains yolk sac-derived haemangioblasts with myeloid and endothelial plasticity and vasculogenic capacity. Poster session presented at the meeting of European Heart Journal. Paris, France: Oxford University Press. 2019 Franke, K., Marshall, H., Worthley, M., & Psaltis, P. J. (2019). A systematic review and meta-analysis on spontaneous coronary artery dissection: epidemiology, risk factors and outcomes. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS. 2019 Solly, E., Hourigan, S. T., Mulangala, J., Psaltis, P. J., Di Bartolo, B., Martin, N., . . . Tan, J. T. M. (2019). Inhibition of miR-181c Rescues Diabetes-Impaired Angiogenesis. Poster session presented at the meeting of DIABETES. San Francisco, CA: AMER DIABETES ASSOC.
DOI2019 Akers, E. J., Mulangala, J., Wilsdon, L. A., Psaltis, P. J., Bursill, C. A., Nicholls, S. J., & Di Bartolo, B. A. (2019). Lipoproteins and Their Modified Forms Regulate Early Stage Vascular Smooth Muscle Cell Calcification. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Boston, MA: LIPPINCOTT WILLIAMS & WILKINS. 2019 Opperman, K., Vandyke, K., Psaltis, P., Croucher, P., Noll, J., & Zannettino, A. (2019). Macrophages as a potential therapeutic target: Clodronate-liposome treatment inhibits multiple myeloma tumour establishment in vivo. Poster session presented at the meeting of CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. CIG MEDIA GROUP, LP.
DOI2018 Takata, K., Duong, M., Honda, S., Sidharta, S. L., Kim, S. W., Shishikura, D., . . . Nicholls, S. J. (2018). Association of Apolipoprotein C-III Distribution With Cholesterol Efflux Capacity and Coronary Plaque Burden. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. 2017 Pisaniello, A., Di Bartolo, B., Liu, G., Gibson, R., Kim, S., Psaltis, P., & Nicholls, S. (2017). THE IMPACT OF ORAL OMEGA-3 FATTY ACID SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN A MOUSE MODEL. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI WoS12017 Takata, K., Duong, M., Kim, S., Di Bartolo, B., Butters, J., Mani, P., . . . Nicholls, S. J. (2017). GREATER CIRCULATING CONCENTRATIONS OF LARGE HDL PARTICLES ASSOCIATE WITH MORE FAVORABLE HDL FUNCTIONALITY IN YOUNG ADULTS. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI2017 Shishikura, D., Sidharta, S. L., Honda, S., Takata, K., Kim, S., Andrews, J., . . . Nicholls, S. J. (2017). THE RELATIONSHIP BETWEEN SEGMENTAL WALL SHEAR STRESS AND NIRS-DERIVED LIPID CORE PLAQUE. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI2017 Mulangala, J., Akers, E. J., Psaltis, P. J., Nicholls, S. J., & Di Bartolo, B. A. (2017). Calcium Dose Dependently Influences Endothelial Cell Angiogenesis. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Minneapolis, MN: LIPPINCOTT WILLIAMS & WILKINS. 2017 Honda, S., Sidharta, S., Shishikura, D., Takata, K., Andrews, J., Kim, S., . . . Nicholls, S. (2017). GENDER RELATED DIFFERENCES OF SERIAL CHANGE IN CORONARY PLAQUE COMPOSITION. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI2017 Honda, S., Sidharta, S., Shishikura, D., Takata, K., Andrews, J., Kim, S., . . . Nicholls, S. (2017). HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AS A DETERMINANT OF CHANGE IN CORONARY PLAQUE LIPID BURDEN ASSESSED BY NEAR INFRARED SPECTROSCOPY. Poster session presented at the meeting of ATHEROSCLEROSIS. Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD.
DOI2016 Pullen, B., Nguyen, T., Gosnell, M., Anwer, A., Goldys, E., Nicholls, S., & Psaltis, P. (2016). Label-free assessment of endothelial cell metabolic state using autofluorescent microscopy. Poster session presented at the meeting of Proceedings of SPIE - The International Society for Optical Engineering. SPIE.
DOI2009 Lau, D. H., Mackenzie, L., Kelly, D. J., Psaltis, P. J., Worthington, M., Rajendram, A., . . . Sanders, P. (2009). Hypertension and atrial fibrillation: a long term study of remodeling in a conscious ovine model. Poster session presented at the meeting of Abstracts of the 82nd Scientific Session of the American Heart Association, as published in Circulation. Orlando, FL: American Heart Association. -
Preprint
Year Citation 2025 Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis.
DOI2024 Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V., Stretton, L. G., Solly, E., . . . Bursill, C. (2024). Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia.
DOI2024 Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A., Rajora, M., Chen, J., . . . Bursill, C. (2024). Multifunctional biomimetic porphyrin-lipid nanoparticles – novel nanoscale theranostics for atherosclerotic cardiovascular disease.
DOI
| 2026-30 Medical Research Future Fund, Early to Mid-Career Researchers (ID:2037779) |
Peter James Psaltis (AI) Title: Personalised cardiovascular risk assessment nano-tools for older people experiencing diseases of ageing: nanotechnology to transform clinical cardiology. |
$4,239,608.53 |
| 2025-27 CALHN CEO Clinical Rapid Implementation Project Scheme Grant |
Peter James Psaltis (Lead Researcher) Title: Systematic lipid profiling and therapy optimisation in vascular surgical patients with Very High-Risk atherosclerotic disease. |
$200,000 |
| 2025-27 Heart Foundation Catalyst Partnership Grant (ID108710-2024_CPG). |
Peter James Psaltis (CIB) Title: Hybrid 3D-printed imaging device for precision heart care. |
$100,000 |
| 2025-27 Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease |
Peter James Psaltis (CIB) Title: Hybrid 3D-printed intravascular imaging device for accurate detection of high-risk coronary artery disease. |
Tranche A Investment $1,000,000 |
| 2024-27 Partnership Projects PRC3 (ID 2044775) |
Peter James Psaltis (CID) Title: Developing an evidence-based clinical pathway for reducing coronary artery disease risks related to per- and polyfluoroalkyl substances (PFAS) in firefighters and communities with high exposure levels. |
$3,741, 231 |
| 2024-27 National Health and Medical Research Council of Australia, Ideas Grant (ID2028599) |
Peter James Psaltis (Associate Investigator) Title: Predicting delirium vulnerability from pre-surgery neurophysiological measures. |
$1,215,441 |
| 2024-27 National Health and Medical Research Council of Australia, Ideas Grant (ID2029177) |
Peter James Psaltis (Associate Investigator) Title: Inhibition of asialoglycoprotein receptor 1: a novel strategy for atherosclerosis prevention. |
$1,184,728 |
| 2024 Adelaide Medical School, The University of Adelaide, Mature Grant Development Award | Peter James Psaltis | $62,972 |
| 2023-27 National Health and Medical Research Council of Australia, Medical Research Future Fund |
Peter James Psaltis (CIG) Title: Towards a culturally appropriate coordination, rehabilitation and secondary prevention model in primary care for Aboriginal people hospitalised with chronic disease. |
$2,388,524.70 |
| 2023-26 National Heart Foundation of Australia, Level 3 Future Leaders Fellowship (ID106656) |
Peter James Psaltis (CIA) Title: Defining a new player in atherosclerosis: The role of Adventitial Endothelial-Macrophage Progenitor Cells as an “outside-in” driver of plaque growth and stability. |
$693,200 |
|
2023-26 National Health and Medical Research Council of Australia, Development Grant (ID GNT2022337) |
Peter James Psaltis (CIB) Title: Hybrid 3D-printed imaging catheter for more accurate cardiovascular disease detection. |
$985,058.50 |
| 2023-25 The Hospital Research Foundation Innovations in Disease Diagnostics Grant (ID 2022-CP-IDMH-014-83100) |
Peter James Psaltis (CIB) Title: More accurate detection of heart disease in patients using the world's smallest 3D-printed imaging catheter. |
$250,000 |
|
2023-25 The Hospital Research Foundation (ID 2022-CP-Heart-010-83100) |
Peter James Psaltis (CIA) Title: The “Can SeMaglutide Achieve Stabilisation of coronary atHerosclerosis after Myocardial Infarction (SMASH-MI)” study. |
$250,000 |
|
2022-25 National Health and Medical Research Council of Australia (MRF2016053) |
Peter James Psaltis (CIB) Title: The Asialoglycoprotein Receptor 1 (ASGR1): a novel target for atherosclerosis. |
$999,989.20 |
|
2022-25 National Health and Medical Research Council of Australia (MRF2016221) |
Peter James Psaltis (Associate Investigator) Title: Atheroma Progression in Clonal Haematopoiesis Investigation with Imaging, Biomarkers and Genomic Sequencing (ARCHIMEDES) . |
$996,384.68 |
| 2022-24 National Health and Medical Research Council of Australia, Ideas Grant (ID2010804) |
Peter James Psaltis (Associate Investigator) Title: Measuring healthy ageing: finding an autophagy biomarker for a scalable clinical test. |
$818,964.40 |
|
2022-24 The Hospital Research Foundation (ID 2022-CP-Heart-023) |
Peter James Psaltis (Associate Investigator) Title: Biomechanical stress profiling of coronary atherosclerosis: Towards predicting plaque progression. |
$250,000 |
| 2022 Vascular Foundation Grant |
Peter James Psaltis (CIB) Title: Evaluation of a novel blood-based biomarker to measure autophagy as a driver of atherosclerotic peripheral artery disease. |
$30,000 |
| 2022 Channel 7 Children’s Research Foundation (ID 20658466) |
Peter James Psaltis (CIB) Title: Human umbilical cord-derived haemangioblasts: discovery of a robust stem cell population for skin wound healing in children. |
$40,000 |
| 2020-25 National Health and Medical Research Council of Australia, Centres of Research Excellence (ID1196629) |
Peter James Psaltis (CIH) Title: NHMRC Centre of Research Excellence for Better Outcomes in Coronary Artery Disease. |
$2,500,000 |
| 2021-22 The Hospital Research Foundation Translational Grant (ID C-PJ-004_Transl-2020) |
Peter James Psaltis (CIB) Title: World’s smallest 3D-printed imaging catheter to identify patients at high risk for myocardial infarction and optimise treatments. |
$70,000 |
| 2021-23 National Health and Medical Research Council of Australia, Ideas Grant (ID2001541) |
Peter James Psaltis (CIA) Title: Defining a new player in atherosclerosis: The role of Adventitial Haemangioblasts as an "outside-in" driver of plaque growth and stability. ** Winner of Marshall Warren Innovation Award. |
$728,004.50 |
| 2021-24 National Health and Medical Research Council of Australia, Ideas Grant (ID2001646) |
Peter James Psaltis (Associate Investigator) Title: Serial imaging of molecular and microstructural changes in atherosclerosis: tracking plaques towards destabilisation. |
$992,112 |
| 2020-2021 National Heart Foundation of Australia, Vanguard Grant (ID102981) |
Peter James Psaltis (CIA) Title: What role do local stem cells play in atherosclerosis? |
$140,000 |
| 2020-2022 National Health and Medical Research Council of Australia, Development Grant (ID1175142) |
Peter James Psaltis (CIC) Title: Bioinvisible stents – a new device coating to repair cardiovascular disease. |
$671,960 |
| 2020-2024 National Health and Medical Research Council of Australia, Clinical Trials and Cohort Studies (ID1187193) |
Peter James Psaltis (CIJ) Title: COLchicine CARDIovascular Outcomes in Acute Coronary Syndrome (COLCARDIO-ACS) Study. |
$4,238,895.50 |
| 2020-2023 National Health and Medical Research Council of Australia, MRFF (ID1201375) |
Peter James Psaltis (Associate Investigator) Title: Using Polygenic Risk Scores to Target Statin Therapy in Primary Prevention. |
$1,400,000 |
| 2020-2023 National Health and Medical Research Council of Australia, Ideas Grant (ID1184571) |
Peter James Psaltis (Associate Investigator) Title: Novel nanoscale theranostic applications of porphysomes in atherosclerotic cardiovascular disease. |
$632,690 |
| 2020 South Australian Health and Medical Research Institute, seed funding. |
Peter James Psaltis (CIB) Title: Finding disease drivers for atherosclerosis: measurement of autophagic flux in a human cohort. |
$30,000 |
| 2019-2022 National Health and Medical Research Council of Australia, Level 2 Career Development Fellowship (ID1161506) |
Peter James Psaltis (CIA) Title: New approaches to target plaque inflammation in atherosclerosis. |
$386,724 |
| 2019-2022 National Heart Foundation of Australia, Level 2 Future Leaders Fellowship (ID102056) |
Peter James Psaltis (CIA) Title: New approaches to target plaque inflammation in atherosclerosis. |
$200,000 |
| 2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1142794) |
Peter James Psaltis (CIA) Title: The novel role of Eukaryotic Elongation Factor 2 Kinase (eEF2K) in atherosclerosis. |
$650,531 |
| 2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1140996) |
Peter James Psaltis (CIC) Title: Bone marrow macrophages: “Resident Evil” in the establishment and progression of multiple myeloma. |
$570,585 |
| 2018-2020 National Health and Medical Research Council of Australia, Project Grant (ID1138917) |
Peter James Psaltis (Associate Investigator) Title: Role for zinc and ZIP2 in the action of nitric oxide and in vascular protection against cigarette smoke and cardiovascular disease. |
$685,940.60 |
| 2018 Sylvia and Charles Viertel Charitable Foundation Clinical Investigator Award (VIERCI2017016) |
Peter James Psaltis (CIA) Title: Colchicine for coronary plaque modification in acute coronary syndrome. |
$85,000 |
| 2018 Royal Australasian College of Physicians, Career Development Fellowship |
Peter James Psaltis (CIA) Title: A Novel Role for Adventital Macrophage Progenitor Cells (AMPCs) in providing a local source of macrophages in atherosclerosis. |
$100,000 |
| 2018 National Heart Foundation of Australia, Tom Simpson Trust Fund |
Peter James Psaltis (CIA)
|
$16,500 |
| 2018 Foundation for Children. Project (ID 289) |
Peter James Psaltis (CIC) Title: Improving the long-term cardio-metabolic health of preterm infants through nutritional interventions: A role for omega-3 fatty acids? |
$124,550 |
| 2017-2020 NHMRC Project Grant (ID 1127159) |
Peter James Psaltis (CIA) Title: A study of the plaque - modifying actions of colchicine in stable and unstable atherosclerosis: from mouse models to clinical imaging |
$1,198,460 |
| 2017 National Heart Foundation of Australia, Vanguard Project Grant (ID 101370) |
Peter James Psaltis (CIA) Title: Colchicine for coronary plaque modification in acute coronary syndrome - A serial optical coherence tomography study |
$75,000 |
| 2017 National Heart Foundation of Australia, Tom Simpson Trust Fund | Peter James Psaltis (CIA) | $9,150 |
| 2017 Abbott Vascular Pty Ltd, Research Grant | Peter James Psaltis (CIA) | $10,000 |
| 2016 5th International Congress on Lipid Metabolism and Atherosclerosis, Travel Grant | Peter James Psaltis | $1,500 |
| 2015-2017 NHMRC Project Grant (ID 1086796) |
Peter James Psaltis (CIA) Title: A study of the origins of macrophages in healthy and atherosclerotic vasculature focusing on a novel population of resident adventitial macrophage progenitor cells (AMPCs) |
$451,125.50 |
| 2015-2018 National Heart Foundation of Australia, Future Leadership Fellowship (FLF100412) |
Peter James Psaltis (CIA) Title: Investigating the development of macrophages in atherosclerosis through a novel pathway of resident adventitial macrophage progenitor cells |
$412,000.00 |
| 2014-2020 ARC Centre of Excellence |
Peter James Psaltis (Associate Investigator) Centre for Nanoscale Biophotonics |
$23,000,000 |
| 2010-2014 NHMRC Post-doctoral Overseas Biomedical Fellowship (ID 0627055) |
Peter James Psaltis (CIA) Title: The myelopoietic potential of vascular adventitial progenitor cells (APCs) and their role in atherosclerosis |
$369,519 |
| 2010 Royal Australasian College of Physicians, Marjorie Hooper Overseas Fellowship | Peter James Psaltis | $20,000 |
| 2006-2009 NHMRC (co-funded), Post-graduate Biomedical Scholarship |
Peter James Psaltis Title: A study of the properties of STRO-1 selected mesenchymal stem cells and their potential for cardiac repair |
$110,385 |
| Date | Position | Institution Name |
| 2024 - | Level E, Clinical Academic, Faculty of Health and Medical Sciences, Adelaide Medical School | University of Adelaide |
| 2019 - 24 | Level D, Clinical Academic, Faculty of Health and Medical Sciences, Adelaide Medical School | University of Adelaide |
| 2015 - 18 | Level C, Clinical Academic | University of Adelaide |
| 2004 - 14 | Senior Lecturer, School of Medicine | University of Adelaide |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2025 Principal Supervisor The role of biomechanical forces in coronary atherosclerosis progression after myocardial infarction. Doctor of Philosophy Doctorate Part Time Dr Alex Binnie 2025 Principal Supervisor Exploring novel approaches to residual inflammation in coronary artery disease Doctor of Philosophy Doctorate Full Time Dr Rajesh Pathy 2025 Principal Supervisor Novel INfluential Factors in the natural histOry of Non-Obstructive Coronary Artery disease syndrome (INFO-NOCA) study Doctor of Philosophy Doctorate Full Time Ms Dang Xuan Anh Tran 2024 Principal Supervisor The role of coding and non-coding RNA in atherosclerotic plaque phenotype in diabetic vs non-diabetic patients with peripheral arterial disease Doctor of Philosophy Doctorate Part Time Dr Benjamin Thurston 2024 Principal Supervisor Predictors of recurrent ischaemic events post myocardial infarction in patients with type 2 diabetes mellitus Master of Philosophy (Clinical Science) Master Full Time Miss Momina Ahmed Allahwala 2024 Co-Supervisor Improved classification of cardiovascular plaques in intravascular imaging using deep learning. Doctor of Philosophy Doctorate Full Time Mr Yi Chen 2024 Co-Supervisor Continuous imaging of molecular and microstructural changes in atherosclerosis by a 3d-printed multimodal endoscope Doctor of Philosophy Doctorate Full Time Miss Yujia Kong 2023 Co-Supervisor The role of the asialoglycoprotein receptor-1 in immune cell regulation of atherosclerosis Doctor of Philosophy Doctorate Full Time Mr Demeke Geremew Debebe 2023 Principal Supervisor New Predictive Factors that Drive Coronary Artery Disease Doctor of Philosophy Doctorate Full Time Miss Naomi Elizabeth Wattchow 2023 Co-Supervisor Biomechanical Analysis of Diseased Coronary Arteries Doctor of Philosophy Doctorate Full Time Mr Yaofeng Ju 2022 Principal Supervisor The Evaluation and Validation of Autophagy as a Novel Biomarker of Coronary Artery Disease Doctor of Philosophy Doctorate Part Time Dr Mau Tam Nguyen 2021 Principal Supervisor Population Based Studies of Stroke Incidence, Subtypes, Treatments and Outcomes in South Australia Doctor of Philosophy Doctorate Part Time Mr Joshua Mahadevan -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2020 - 2024 Co-Supervisor Nonlinear Biomechanics of Aortic System Doctor of Philosophy Doctorate Full Time Ms Xiaochen Wang 2019 - 2024 Principal Supervisor Applications of Clinical Lipidomics to Metabolic Diseases: Methodology and Implications Doctor of Philosophy Doctorate Full Time Mr Jake White 2019 - 2023 Co-Supervisor Fluid-Structure Interaction for Heart Attack Prediction Doctor of Philosophy Doctorate Full Time Mr Harry James Carpenter 2019 - 2023 Principal Supervisor Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Ms Sanuri Rashmitha Liyanage 2018 - 2022 Principal Supervisor Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues Doctor of Philosophy Doctorate Full Time Miss Anna Emilie Williamson 2018 - 2019 Co-Supervisor Plaque Rupture Prediction in Human Arteries Doctor of Philosophy Doctorate Full Time Dr Alireza Gholipour 2017 - 2020 Co-Supervisor Control of adipocyte differentiation and metabolism by mitogen-activated protein kinase (MAPK)-interacting kinases (MNKs) Doctor of Philosophy Doctorate Full Time Mr James Edward Merrett 2017 - 2021 Co-Supervisor Macrophages, Myeloma, Mouse Models and Methodologies Doctor of Philosophy Doctorate Full Time Mrs Khatora Shanae Opperman 2017 - 2021 Principal Supervisor Molecular Mediators of Macrophage Foam Cell Formation and Atherosclerosis and their Pharmacological Modification Doctor of Philosophy Doctorate Full Time Ms Sanuja Fernando 2016 - 2022 Co-Supervisor OPTIMISATION OF SURGICAL TIMING IN RHEUMATIC MITRAL VALVE
DISEASEDoctor of Philosophy Doctorate Full Time APrf Ross Roberts-Thomson 2015 - 2020 Co-Supervisor Triglyceride Rich Lipoproteins and Apolipoprotein C-III in Atherosclerosis Doctor of Philosophy Doctorate Full Time Miss Wenru Pan 2008 - 2011 Co-Supervisor The Effects of Omega-3 Fatty Acids in an Ovine Model of Anthracycline-induced Non-ischaemic Cardiomyopathy Master of Medical Science Master Full Time Mr Angelo Carbone
-
Board Memberships
Date Role Board name Institution name Country 2024 - ongoing Member Board Corcillum Systems Pty Ltd Australia 2024 - ongoing Member Board Australian Cardiovascular Alliance (ACvA) Australia 2018 - 2021 Member Board South Australian Postgraduate Medical Education Association (SAPMEA) Australia -
Committee Memberships
Date Role Committee Institution Country 2025 - ongoing Member Executive, Philanthropy Committee South Australian Health and Medical Research Institute (SAHMRI) Australia 2023 - ongoing Co-Chair SA Cardiovascular Research Network Executive Committee Heart Foundation Australia 2020 - ongoing Member Scientific Committee Cardiac Society of Australia and New Zealand Australia 2020 - ongoing Member Steering Committee NHMRC-funded COLCARDIO-ACS study Australia 2020 - ongoing Member Steering Committee NHMRC-funded Da Vinci study Australia 2019 - ongoing Member Leadership Executive Committee, Lifelong Health Theme South Australian Health and Medical Research Institute (SAHMRI) Australia 2018 - ongoing Member Executive Committee Australian Atherosclerosis Society Australia 2017 - ongoing Member Clinical Council Australian Atherosclerosis Society Australia 2017 - ongoing Member Grant Review Panel National Health and Medical Research Council Australia 2016 - ongoing Member Reconciliation Action Plan (RAP) Committee South Australian Health and Medical Research Institute (SAHMRI) Australia 2016 - ongoing Member Research Executive Committee South Australian Health and Medical Research Institute (SAHMRI) Australia 2016 - ongoing Member Acute Coronary Syndrome Task Force SA Health Australia 2016 - ongoing Member Research Executive Committee South Australian Health and Medical Research Institute (SAHMRI) Australia 2015 - ongoing Member Bioscience Pillar Committee Member South Australian Health and Medical Research Institute (SAHMRI) Australia 2015 - 2016 Member Scientific Program Committee and Interventional Stream Leader, 64th Annual Scientific Meeting Cardiac Society of Australia and New Zealand Australia -
Memberships
Date Role Membership Country 2018 - ongoing Member American College of Cardiology United States 2018 - ongoing Member Australian Vascular Biology Society Australia 2017 - ongoing Member Australian Atherosclerosis Society Australia 2016 - ongoing Member Cardiac Society of Australia and New Zealand (Fellow) Australia 2016 - ongoing Member Australian Cardiovascular Alliance Australia 2016 - ongoing Member Acute Coronary Syndrome Task Force, SA Health Australia 2014 - ongoing Member International Society for Heart Research Australia 2011 - ongoing Member American Heart Association, Councils of Basic Cardiovascular Sciences and Arteriosclerosis, Thrombosis and Vascular Biology United States 2009 - ongoing Member Australian Society of Medical Research Australia 2009 - ongoing Member International Society of Heart Research Australia 2005 - ongoing Member Fellow, Royal Australasian College of Physicians Australia 2004 - ongoing Member Cardiac Society of Australia and New Zealand Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2025 - ongoing Associate Editor European Journal of Preventive Cardiology - United Kingdom 2025 - ongoing Editor Special Issue Editor - Cardiovascular-Kidney-Metabolic Syndrome, Heart, Lung and Circulation - Australia 2024 - 2025 Editor Special Issue Editor, Role of Colchicine in Atherosclerosis, Frontiers in Cardiovascular Medicine - Switzerland 2024 - ongoing Editor International Editorial Board Member, JRSM Cardiovascular Disease - United Kingdom 2018 - ongoing Board Member Cardiovascular Research - United Kingdom 2017 - ongoing Board Member Cardiovascular Diagnosis and Therapy - China 2017 - ongoing Associate Editor Interventional Cardiology, Heart, Lung and Circulation - United States 2015 - 2016 Associate Editor General Cardiology, Heart, Lung and Circulation - Australia 2011 - ongoing Board Member Journal of Geriatric Cardiology - China -
Offices Held
Date Office Name Institution Country 2021 - ongoing Co-lead, Lifelong Health Theme South Australian Health and Medical Research Institute (SAHMRI) Australia 2021 - ongoing Leader, Heart and Vascular Program South Australian Health and Medical Research Institute (SAHMRI) Australia 2020 - ongoing President Australian Atherosclerosis Society Australia 2019 - 2020 Scientific Program Chair, Annual Scientific Meeting Cardiac Society of Australia and New Zealand Australia 2019 - ongoing Principal Site Investigator, NHMRC-funded CAUGHT-CAD study Royal Adelaide Hospital Australia 2018 - ongoing Principal Site Investigator, NHMRC-funded CAUGHT-CAD study Royal Adelaide Hospital Australia 2017 - ongoing Head of Optical Coherence Tomography Imaging Core Laboratory South Australian Health and Medical Research Institute (SAHMRI) Australia 2016 - ongoing National Lead Investigator, CLEAR study ESPERION Therapeutics Australia 2016 - 2020 Deputy Leader, Heart Heath Theme South Australian Health and Medical Research Institute (SAHMRI) Australia 2015 - ongoing Co-director, Vascular Research Centre, Heart Health Theme South Australian Health and Medical Research Institute - 2015 - 2017 Site Investigator, CARAT study Royal Adelaide Hospital Australia
Connect With Me
External Profiles
